Genmab — November 2019
-
-
2400 kan sagtens komme i spil ultimo 2020. Vi skal ikke undervurdere flaskehalsen som stadigvæk ser ud til at præge salget i US. Se hvor hurtig ROW har indhentet US. Denne flaskehals vil med SC forsvinde ret hurtigt og den pukkel kan sagtens udgøre et ret stort beløb, men det afhænger af om det er det træge system eller det er træge læger der "bremser" salget, Mit gæt er at stolelegen har "bremset" salget og vi vil se en stor reaktion på salget når SC kommer. Læg dertil Ofa, Tisa og diverse data
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
